Matches in Wikidata for { <http://www.wikidata.org/entity/Q90359061> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q90359061 description "artículu científicu espublizáu en xunu de 2018" @default.
- Q90359061 description "scientific article published on 01 June 2018" @default.
- Q90359061 description "wetenschappelijk artikel" @default.
- Q90359061 description "наукова стаття, опублікована в червні 2018" @default.
- Q90359061 name "Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival" @default.
- Q90359061 name "Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival" @default.
- Q90359061 type Item @default.
- Q90359061 label "Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival" @default.
- Q90359061 label "Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival" @default.
- Q90359061 prefLabel "Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival" @default.
- Q90359061 prefLabel "Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival" @default.
- Q90359061 P1433 Q90359061-E6B41B87-C7BB-4AC0-BFF2-EDB97A999209 @default.
- Q90359061 P1476 Q90359061-2D951D4E-E065-414E-9793-B1409F10E288 @default.
- Q90359061 P2093 Q90359061-33DCDD28-0362-4579-B253-FC380AD9BC53 @default.
- Q90359061 P2093 Q90359061-36AD0F8A-FDA9-4CF7-AEFB-75DA9843C7EE @default.
- Q90359061 P2093 Q90359061-4135646D-2444-4E6F-B514-0A1374BAA2EF @default.
- Q90359061 P2093 Q90359061-4224B9FD-CEC4-4238-A808-556DAD536272 @default.
- Q90359061 P2093 Q90359061-4D93CC0C-9D2C-4295-8032-360BD883CB8C @default.
- Q90359061 P2093 Q90359061-5C4FBEE6-6CC4-48AD-8F3E-28EB0AB4F1FD @default.
- Q90359061 P2093 Q90359061-8C3F5BF0-0F0B-45C7-8303-8B6A9AE8D143 @default.
- Q90359061 P2093 Q90359061-938CBFF1-198E-4208-AA31-E5BFCBE8B7F1 @default.
- Q90359061 P2093 Q90359061-B35747AF-801E-4B6F-A2B9-F840C04AB242 @default.
- Q90359061 P2093 Q90359061-D77FFB75-B424-4F10-8ED6-ECE0BFE65DAA @default.
- Q90359061 P2093 Q90359061-DFB1BC55-4237-4DAD-B8F4-94329D4E5490 @default.
- Q90359061 P304 Q90359061-88C179D3-B1E5-42C2-9BB8-B12A437C7E07 @default.
- Q90359061 P31 Q90359061-0E0FBC3B-0CEB-4C8B-A838-8556134719CC @default.
- Q90359061 P356 Q90359061-3D5D8731-AA36-43D8-96B9-A7254B66B354 @default.
- Q90359061 P478 Q90359061-5578823B-4472-4598-8CD7-2B6FEB065B69 @default.
- Q90359061 P577 Q90359061-48FBB763-8CD8-4ED8-97DA-3047A0179B20 @default.
- Q90359061 P921 Q90359061-EF46186D-93A1-4806-AE23-2BA02F61CD12 @default.
- Q90359061 P356 MDY151.163 @default.
- Q90359061 P1433 Q326122 @default.
- Q90359061 P1476 "Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival" @default.
- Q90359061 P2093 "E Martin" @default.
- Q90359061 P2093 "G Zogopoulos" @default.
- Q90359061 P2093 "J Asselah" @default.
- Q90359061 P2093 "K Guo" @default.
- Q90359061 P2093 "N Bouganim" @default.
- Q90359061 P2093 "O Donnay" @default.
- Q90359061 P2093 "R Colomer" @default.
- Q90359061 P2093 "R Mondéjar Solís" @default.
- Q90359061 P2093 "T Alcindor" @default.
- Q90359061 P2093 "T France" @default.
- Q90359061 P2093 "V Pacheco-Barcia" @default.
- Q90359061 P304 "v46" @default.
- Q90359061 P31 Q13442814 @default.
- Q90359061 P356 "10.1093/ANNONC/MDY151.163" @default.
- Q90359061 P478 "29 Suppl 5" @default.
- Q90359061 P577 "2018-06-01T00:00:00Z" @default.
- Q90359061 P921 Q212961 @default.